Benzinga | Nov 10, 2020 04:29PM EST

10x Genomics Q3 EPS $(0.65) Misses $(0.30) Estimate, Sales $71.80M Beat $61.23M Estimate

10x Genomics (NASDAQ:TXG) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0.30) by 116.67 percent. This is a 96.97 percent decrease over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $71.80 million which beat the analyst consensus estimate of $61.23 million by 17.26 percent. This is a 17.31 percent increase over sales of $61.21 million the same period last year.